The second firm conducted bi-annual reviews of all fund managers, including those through which the insurer invested via collective investment schemes.
It noted, however, that such research should be conducted under the mantle of preserving modern biodiversity rather than conjuring extinct species from the grave.
Such cross-examination would not unjustifiably limit the right to remain silent, provided it was conducted with due regard to the dictates of trial fairness.